دورية أكاديمية
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
| العنوان: | Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study |
|---|---|
| المؤلفون: | Zhu, Chengpei, Li, Hu, Yang, Xiaobo, Wang, Shanshan, Wang, Yunchao, Zhang, Nan, Wang, Yanyu, Xue, Jingnan, Zhang, Longhao, Ning, Cong, Yang, Xu, Xun, Ziyu, Chao, Jiashuo, Long, Junyu, Sang, XintingAff1, IDs00262023034668_cor15, Zhu, ZhenyuAff2, IDs00262023034668_cor16, Zhao, HaitaoAff1, IDs00262023034668_cor17 |
| المصدر: | Cancer Immunology, Immunotherapy. 72(9):2949-2960 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 03407004 14320851 |
|---|---|
| DOI: | 10.1007/s00262-023-03466-8 |